Inhaled therapy in elderly COPD patients; time for re-evaluation?

Area of Science:

• Respiratory Medicine
• Geriatric Medicine
• Pharmacology

Background:

• Chronic obstructive pulmonary disease (COPD) prevalence increases with age.
• Inhaled therapy is a cornerstone of COPD management.
• Effectiveness of inhaled therapy in the elderly COPD population requires further investigation.

Purpose of the Study:

• To evaluate the effectiveness of inhaled therapy in elderly COPD patients.
• To measure peak inspiratory flow (PIF) in this population.
• To assess patient-perceived benefit from inhaler devices.

Main Methods:

• Recruited 53 elderly COPD patients (mean age 73.5 years).
• Assessed PIF using the 'In-Check Dial' device.
• Collected data via directed questions on inhaler use and perceived benefit.

Main Results:

• Many elderly patients found their metered dose inhalers (pMDIs) and dry powder inhalers (DPIs) difficult to use.
• A significant negative correlation exists between age and PIF (R = 0.84, P<0.0001).
• Inability to generate adequate PIF was common, particularly with higher resistance DPIs, and linked to older age, independent of COPD severity.

Conclusions:

• Elderly COPD patients may not achieve optimal benefit from inhaler therapy.
• Age-related decline in PIF is a significant factor limiting effective inhaler use.
• Further research is needed to optimize inhaled therapy delivery in older adults with COPD.